Computer-assisted drug design
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTComputer-assisted drug designA. J. HopfingerCite this: J. Med. Chem. 1985, 28, 9, 1133–1139Publication Date (Print):September 1, 1985Publication History Published online1 May 2002Published inissue 1 September 1985https://pubs.acs.org/doi/10.1021/jm00147a001https://doi.org/10.1021/jm00147a001research-articleACS PublicationsRequest reuse permissionsArticle Views843Altmetric-Citations82LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increasing drug permeability by one log unit can lead to a decrease in water solubility of up to two log units.
“For instance, increasing drug permeability by one log unit can lead to a decrease in water solubility of up to two log units (102).”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [102]
Cited by
Sorted by citations
Rethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894 · see citing works
Hansch, C. H., Björkroth, J.-P., & Leo, A. J. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600760902 · Cited by 439 · see citing works
Martin, Y. C., Bures, M. G., Danaher, E. A., et al. (1993) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00141577 · Cited by 406 · see citing works
Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure
Wessel, M. D., Jurs, P. C., Tolan, J. W., & Muskal, S. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980029a · Cited by 368 · see citing works
Molecule-pharmacophore superpositioning and pattern matching in computational drug design
Wolber, G., Seidel, T., Bendix, F., & Langer, T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.09.007 · Cited by 315 · see citing works
Kearsley, S. K., & SMITH, G. M. (1990) · Tetrahedron Computer Methodology · doi:10.1016/0898-5529(90)90162-2 · Cited by 313 · see citing works
Dahiyat, B. I., & Mayo, S. L. (1996) · Protein Science · doi:10.1002/pro.5560050511 · Cited by 298 · see citing works
Physicochemical Features of the hERG Channel Drug Binding Site
Fernández, D., Ghanta, A., Kauffman, G. W., & Sanguinetti, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310683200 · Cited by 267 · see citing works
Marshall, G. R. (1987) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.27.040187.001205 · Cited by 245 · see citing works
Molecular similarity and diversity in chemoinformatics: From theory to applications
Maldonado, A. G., Doucet, J. P., Petitjean, M., & Fan, B. (2006) · Molecular Diversity · doi:10.1007/s11030-006-8697-1 · Cited by 239 · see citing works
Artificial Intelligence for Drug Discovery: Are We There Yet?
Hasselgren, C., & Oprea, T. I. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040323-040828 · Cited by 236 · see citing works
“Hopfinger (100) framed this discussion in terms of computer-aided drug design in 1985.”
BackgroundCOMPUTER AIDED DRUG DESIGN: AN OVERVIEW
Surabhi, S., & Singh, B. (2018) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v8i5.1894 · Cited by 169 · see citing works
Hansch, C. H., & Klein, T. E. (1986) · Accounts of Chemical Research · doi:10.1021/ar00132a003 · Cited by 141 · see citing works
Drug Discovery and Development
(2006) · Chemical & Engineering News · doi:10.1021/cen-v084n039.p020 · Cited by 128 · see citing works
Constrained search of conformational hyperspace
Dammkoehler, R. A., Karasek, S. F., Shands, E. F. B., et al. (1989) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf01590992 · Cited by 122 · see citing works
Assessing the reliability of a QSAR model's predictions
He, L., & Jurs, P. C. (2005) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2005.03.003 · Cited by 120 · see citing works
Systematic QSAR Procedures with Quantum Chemical Descriptors
Kikuchi, O. (1987) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19870060406 · Cited by 119 · see citing works
Molecular Organization of Liquid n-Octanol: An X-ray Diffraction Analysis
Franks, N. P., Abraham, M. H., & Lieb, W. R. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600820507 · Cited by 111 · see citing works
Liwo, A., Pincus, M. R., Wawak, R. J., Rackovsky, S. R., dziej, S. O., & Scheraga, H. A. (1997) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199705)18:7 · Cited by 186 · see citing works
Pharmacophore definition and 3D searches
Langer, T., & Wolber, G. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.015 · Cited by 102 · see citing works
3D Printing of Pharmaceutical Application: Drug Screening and Drug Delivery
Gao, G., Ahn, M., Cho, W.-W., Kim, B.-S., & Cho, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091373 · Cited by 108 · see citing works
Ab initiocalculation of molar volumes: Comparison with experiment and use in solvation models
Wong, M. W., Wiberg, K. B., & Frisch, M. J. (1995) · Journal of Computational Chemistry · doi:10.1002/jcc.540160312 · Cited by 94 · see citing works
Recent Developments in Inhibiting Cysteine and Serine Proteases
Demuth, H. (1990) · Journal of enzyme inhibition · doi:10.3109/14756369009030375 · Cited by 87 · see citing works
Prediction of gas chromatographic retention indices of alkylbenzenes
Sutter, J. M., Peterson, T. A., & Jurs, P. C. (1997) · Analytica Chimica Acta · doi:10.1016/s0003-2670(96)00578-8 · Cited by 86 · see citing works
Fragment Screening Using X-Ray Crystallography
Davies, T. G., & Tickle, I. J. (2011) · Topics in current chemistry · doi:10.1007/128_2011_179 · Cited by 82 · see citing works
Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening
Tanrikulu, Y., & Schneider, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2615 · Cited by 82 · see citing works
Topological virtual screening: A way to find new anticonvulsant drugs from chemical diversity
Bruno‐Blanch, L. E., Gálvez, J., & García‐Domenech, R. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00535-3 · Cited by 81 · see citing works
Du, Q.-S., Mezey, P. G., & Chou, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20174 · Cited by 78 · see citing works
Pharmacophoric pattern matching in files of 3D chemical structures: evaluation of search performance
Jakes, S. E., Watts, N., Willett, P., et al. (1987) · Journal of Molecular Graphics · doi:10.1016/0263-7855(87)80044-9 · Cited by 76 · see citing works
Quantitative Structure-Activity Relationships of Cytochrome P-450
Hansch, C. H., & Zhang, L. (1993) · Drug Metabolism Reviews · doi:10.3109/03602539308993972 · Cited by 75 · see citing works
DNA as a target for drug action
Hurley, L. H., & Boyd, F. L. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90067-3 · Cited by 74 · see citing works
Comparative molecular field analysis (CoMFA)
Kim, K. H. (1995) · Springer eBooks · doi:10.1007/978-94-011-1350-2_12 · Cited by 71 · see citing works
Boyd, D. B., Smith, D. W., Stewart, J. J. P., et al. (1988) · Journal of Computational Chemistry · doi:10.1002/jcc.540090414 · Cited by 66 · see citing works
3D QSAR: Current State, Scope, and Limitations
Martin, Y. C. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46858-1_1 · Cited by 63 · see citing works
Computer‐Assisted Molecular Design (CAMD)—An Overview
Frühbeis, H., Klein, R., & Wallmeier, H. (1987) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198704031 · Cited by 62 · see citing works
Molecular modeling of polymers. IV. Estimation of glass transition temperatures
Hopfinger, A. J., Koehler, M. G., Pearlstein, R. A., et al. (1988) · Journal of Polymer Science Part B Polymer Physics · doi:10.1002/polb.1988.090261001 · Cited by 61 · see citing works
Self-citationA review and examination of the mathematical spaces underlying molecular similarity analysis
Johnson, M. A. (1989) · Journal of Mathematical Chemistry · doi:10.1007/bf01166045 · Cited by 61 · see citing works
Successes of Computer‐Assisted Molecular Design
Boyd, D. B. (1990) · Reviews in computational chemistry · doi:10.1002/9780470125786.ch10 · Cited by 62 · see citing works
Boyd, D. B. (1990) · Reviews in computational chemistry · doi:10.1002/9780470125786.ch9 · Cited by 61 · see citing works
Searching for pharmacophores in large coordinate data bases and its use in drug design.
Sheridan, R. P., Rusinko, A., Nilakantan, R., et al. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8165 · Cited by 60 · see citing works
In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10
Eissa, I. H., Khalifa, M. M., Elkaeed, E. B., Hafez, E. S. E., Alsfouk, A. A., & Metwaly, A. M. (2021) · Molecules · doi:10.3390/molecules26206151 · Cited by 58 · see citing works
“All these techniques have great popularity and have been used in both academic fields in addition to the pharmaceutical industries [28].”
BackgroundGeneration of QSAR sets with a self-organizing map
Guha, R., Serra, J. R., & Jurs, P. C. (2004) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2004.03.003 · Cited by 58 · see citing works
Moţoc, I., Dammkoehler, R. A., Mayer, D., et al. (1986) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19860050305 · Cited by 57 · see citing works
Kaushik, A. C., Kumar, S., Wei, D., et al. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00023 · Cited by 55 · see citing works
“In this study, we have reported the structure based virtual screening to find the hit compounds that can be used to develop potential leads for novel agonists of GPR142 (Gund et al., 1974; Hopfinger, 1985; Guner, 2000).”
BackgroundUllmann, G. M., Hauswald, M., Jensen, A., et al. (1997) · Biochemistry · doi:10.1021/bi971241v · Cited by 53 · see citing works
Comparison of Fragment Weighting Schemes for Substructural Analysis
Ormerod, A., Willett, P., & Bawden, D. (1989) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19890080207 · Cited by 51 · see citing works
Prediction of gas chromatographic retention indexes of selected olefins
Rohrbaugh, R. H., & Jurs, P. C. (1985) · Analytical Chemistry · doi:10.1021/ac00291a008 · Cited by 50 · see citing works
Systematic search in conformational analysis
Beusen, D. D., Shands, E. F. B., Karasek, S. F., et al. (1996) · Journal of Molecular Structure THEOCHEM · doi:10.1016/s0166-1280(96)04565-4 · Cited by 49 · see citing works
New methods in computer-aided drug design
Sheridan, R. P., & Venkataraghavan, R. (1987) · Accounts of Chemical Research · doi:10.1021/ar00141a002 · Cited by 49 · see citing works
Towards interoperable and reproducible QSAR analyses: Exchange of datasets
Spjuth, O., Willighagen, E., Guha, R., Eklund, M., & Wikberg, J. E. S. (2010) · Journal of Cheminformatics · doi:10.1186/1758-2946-2-5 · Cited by 48 · see citing works
Moro, S., Li, A., & Jacobson, K. A. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980080e · Cited by 47 · see citing works
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands
Lee-Dutra, A., Arienti, K. L., Buzard, D. J., Hack, M. D., Khatuya, H., Desai, P. J., Nguyen, S. M., Thurmond, R. L., Karlsson, L., Edwards, J. P., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.117 · Cited by 46 · see citing works
Mosier, P. D., Counterman, A. E., Jurs, P. C., et al. (2002) · Analytical Chemistry · doi:10.1021/ac0112059 · Cited by 45 · see citing works
A transaction costs analysis of innovations in the organization of pharmaceutical R & D
Tapon, F. (1989) · Journal of Economic Behavior & Organization · doi:10.1016/0167-2681(89)90055-3 · Cited by 45 · see citing works
Serra, J. R., Thompson, E., & Jurs, P. C. (2003) · Chemical Research in Toxicology · doi:10.1021/tx020077w · Cited by 44 · see citing works
The Electron‐Topological Approach to the QSAR Problem
Bersuker, I. B., & Димогло, А. С. (1991) · Reviews in computational chemistry · doi:10.1002/9780470125793.ch10 · Cited by 44 · see citing works
Oros, G., Cserháti, T., & Forgács, E. (2003) · Chemosphere · doi:10.1016/s0045-6535(03)00158-9 · Cited by 43 · see citing works
A molecular field-based similarity approach to pharmacophoric pattern recognition
Mestres, J., Rohrer, D. C., & Maggiora, G. M. (1997) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(97)00003-x · Cited by 42 · see citing works
Automatic superposition of drug molecules based on their common receptor site
Kato, Y., Inoue, A., Yamada, M., et al. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00130398 · Cited by 41 · see citing works
Patankar, S. J., & Jurs, P. C. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci020045e · Cited by 40 · see citing works
New developments in cardiac glycoside structure-activity relationships
REPKE, K. R. H. (1985) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(85)90126-9 · Cited by 40 · see citing works
Fractional description of free energies of solvation
Luque, F. J., Barril, X., & Orozco, M. (1999) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008036526741 · Cited by 37 · see citing works
Benigni, R., Andreoli, C., & Giuliani, A. (1989) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(89)90036-5 · Cited by 37 · see citing works
2 Structural Aspects of Antineoplastic Agents – A New Approach
Cheng, C. (1988) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70277-7 · Cited by 37 · see citing works
Approaches to Three‐Dimensional Quantitative Structure‐Activity Relationships
Greco, G., Novellino, E., & Martin, Y. C. (1997) · Reviews in computational chemistry · doi:10.1002/9780470125885.ch4 · Cited by 37 · see citing works
Screening of novel pentacyclo-undecylamines for neuroprotective activity
Geldenhuys, W. J., Terre’Blanche, G., der Schyf, C. J. V., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02701-2 · Cited by 36 · see citing works
Evolutionary and genetic methods in drug design
Parrill, A. L. (1996) · Drug Discovery Today · doi:10.1016/s1359-6446(96)10045-3 · Cited by 34 · see citing works
Mishra, R. K., García‐Domenech, R., & Gálvez, J. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000303c · Cited by 34 · see citing works
Collagen–ligand interaction in dentinal adhesion: computer visualization and analysis
Vaidyanathan, J., Vaidyanathan, T. K., Yadav, P., et al. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00038-2 · Cited by 34 · see citing works
Conformationally Restricted TRH Analogs: A Probe for the Pyroglutamate Region
Rutledge, L. D., Perlman, J. H., Gershengorn, M. C., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960053k · Cited by 33 · see citing works
A Perspective of Modern Methods in Computer‐Aided Drugc design
Balbes, L. M., Mascarella, S. W., & Boyds, D. B. (1994) · Reviews in computational chemistry · doi:10.1002/9780470125823.ch7 · Cited by 33 · see citing works
Constrained peptidomimetics: building bicyclic analogs of pyrazoline derivatives
Liu, B., Brandt, J. D., & Moeller, K. D. (2003) · Tetrahedron · doi:10.1016/j.tet.2003.09.027 · Cited by 32 · see citing works
Property-Based Drug Design Merits a Nobel Prize
Pennington, L. D., Hesse, M. J., Koester, D. C., McAtee, R. C., Qunies, A. M., & Hu, D. X. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01345 · Cited by 35 · see citing works
Some observations on classical QSAR
Topliss, J. G. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02174527 · Cited by 30 · see citing works
Laber, B., Usunow, G., Wiecko, E., et al. (1999) · Pesticide Biochemistry and Physiology · doi:10.1006/pest.1999.2401 · Cited by 29 · see citing works
Henczi, M., Nagy, J., & Weaver, D. F. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb05807.x · Cited by 29 · see citing works
“As the lipophilicity of a drug is a crucial factor in determining its bioavailability to the receptor microenvironment, the octanol-water partition coefficient, expressed as log P, plays a central role in anticonvulsant QSAR (Lien et a1 1975; Hopfinger 1985).”
BackgroundDrug Discovery and Development
Williams, M. J., & Malick, J. B. (1987) · Drug Discovery and Development · doi:10.1007/978-1-4612-4828-6_1 · Cited by 29 · see citing works
Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence
Moreira‐Filho, J. T., Silva, A. C., Dantas, R. F., Gomes, B. F., Neto, L. R. S., Brandão-Neto, J., Owens, R. J., Furnham, N., Neves, B. J., Silva, F. P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642383 · Cited by 32 · see citing works
Design and development of sequence selective lexitropsin DNA minor groove binders
Lown, J. W. (1995) · Drug Development Research · doi:10.1002/ddr.430340207 · Cited by 27 · see citing works
An algorithm for the representation and computation of supermolecular surfaces and volumes
Karfunkel, H. R., & Eyraud, V. (1989) · Journal of Computational Chemistry · doi:10.1002/jcc.540100505 · Cited by 26 · see citing works
Comparison and evaluation of enteric polymer properties in aqueous solutions
Davis, M. B., ICHIKAWA, I., Williams, E. J., et al. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90241-3 · Cited by 25 · see citing works
Potential targets for antiviral chemotherapy
Prusoff, W. H., Lin, T., & Zucker, M. L. (1986) · Antiviral Research · doi:10.1016/0166-3542(86)90014-8 · Cited by 25 · see citing works
Molecular van der Waals Space and Topological Indices from the Distance Matrix
Ciubotariu, D., Medeleanu, M., Vlaia, V., et al. (2004) · Molecules · doi:10.3390/91201053 · Cited by 24 · see citing works
Computational Science New Horizons and Relevance to Pharmaceutical Design
Briggs, J. M., Marrone, T. J., & McCammon, J. A. (1996) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(96)00068-0 · Cited by 24 · see citing works
Mapping the binding site of the nucleoside transporter protein: a 3D-QSAR study
Viswanadhan, V. N., Ghose, A. K., & Weinstein, J. N. (1990) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(90)90271-g · Cited by 24 · see citing works
Designing novel nicotinic agonists by searching a database of molecular shapes
Sheridan, R. P., & Venkataraghavan, R. (1987) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf01677047 · Cited by 24 · see citing works
Computergestütztes Moleküldesign (CAMD) – ein Überblick
Frühbeis, H., Klein, R. W., & Wallmeier, H. (1987) · Angewandte Chemie · doi:10.1002/ange.19870990506 · Cited by 24 · see citing works
Simay, A., Prokal, L., & Bodor, N. S. (1989) · Tetrahedron · doi:10.1016/s0040-4020(01)81305-3 · Cited by 23 · see citing works
Jain, A. N. (2017) · Journal of Physics Conference Series · doi:10.1088/1742-6596/884/1/012072 · Cited by 21 · see citing works
“Hanschet al. suggested that if one employed cluster analysis on all possible substituent’s and included one member from each of the clusters of similar substitutions, the designed ligands would show more independent variation in physical properties [35].”
BackgroundJaroszewski, J. W., Jensen, P. S., Cornett, C., et al. (1988) · Biochemical Systematics and Ecology · doi:10.1016/0305-1978(88)90112-3 · Cited by 21 · see citing works
Systematic search strategies in conformational analysis
Beusen, D. D. (1996) · Drug Discovery Today · doi:10.1016/s1359-6446(96)80009-2 · Cited by 19 · see citing works
Chapter 27 Molecular Modeling as an Aid to Drug Design and Discovery
GUND, P., Halgren, T. A., & SMITH, G. M. (1987) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61175-6 · Cited by 19 · see citing works
Accelerating the drug design process through parallel inductive logic programming data mining
Graham, J. A., Page, C. D., & Kamal, A. (2004) · doi:10.1109/csb.2003.1227345 · Cited by 18 · see citing works
A review of approaches in computer-aided drug design in drug discovery
Padole, S. S., Asnani, A. J., Chaple, D., & Katre, S. G. (2022) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2022.19.2.0161 · Cited by 17 · see citing works
On the importance of topological descriptors in understanding structure–property relationships
Stanton, D. T. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9204-9 · Cited by 17 · see citing works
Molecular surface comparison. 2. Similarity of electrostatic vector fields in drug design
Blaney, F. E., Edge, C., & Phippen, R. W. (1995) · Journal of Molecular Graphics · doi:10.1016/0263-7855(95)00015-x · Cited by 17 · see citing works
Chapter 26 Approaches Toward the Design of Sequence-Specific Drugs for DNA
Hurley, L. H., & Boyd, F. L. (1987) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61174-4 · Cited by 16 · see citing works
Doweyko, A. M. (1991) · Journal of Mathematical Chemistry · doi:10.1007/bf01200827 · Cited by 16 · see citing works
Protein-Protein Docking Methods
Marshall, G. R., & Vakser, I. A. (2006) · Springer eBooks · doi:10.1007/0-387-24532-4_6 · Cited by 16 · see citing works
Grid-derived structure-based 3D pharmacophores and their performance compared to docking
Cross, S., & Cruciani, G. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.09.002 · Cited by 15 · see citing works
- Authors
- Hopfinger, A. J.
- Corresponding author
- Hopfinger, A. J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1985-09
- Volume
- 28
- Issue
- 9
- Pages
- 1133-1139
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1980417767
- Cited by
- 212
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 3 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 3 · 2013: 3 · 2012: 1
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
- Keywords
- computer-aided drug design, molecular modeling, structure-based drug design, molecular docking, virtual screening
- MeSH terms
- Angiotensin-Converting Enzyme Inhibitors, Antibiotics, Antineoplastic, Chemistry, Computers, DNA, Drug Industry, Folic Acid Antagonists, Models, Molecular, Molecular Conformation, Nalidixic Acid, Naphthacenes, Norfloxacin, Patents as Topic, Receptors, Drug, Structure-Activity Relationship, Technology, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review